At this year's Chemspec Europe, due to be held in Barcelona, Spain, on June 13-14, 2012, Saltigo GmbH will again demonstrate its expertise as a premium provider in the field of custom synthesis for the agrochemical and pharmaceutical industries and for fine chemicals. For Saltigo – a wholly owned subsidiary of LANXESS – non-exclusive "multi-customer" products is another area of activity that is gaining increasing importance.
"Our exclusive synthesis customers reap the full benefits of our strengths and expertise in exactly the same way as buyers of our multi-customer products. Alongside our comprehensive technology portfolio and many decades of experience in process development and optimization, we also offer excellent professional project management services. For our customers, this means maximum transparency, adherence to deadlines and reliable delivery," says Jörg Schneider, head of the Agro & Fine Chemicals business line at Saltigo. The internationally experienced manager is convinced that increasing market globalization and the growth markets of Asia and South America offer excellent prospects for Saltigo. "Especially in the agricultural segment, where we already hold an excellent market position, we intend to establish ourselves as THE optimal global development and project partner," says Schneider. In conjunction with the company’s agricultural customers, he continues, it is important to face up to the challenges of the future, which include an ever-growing world population, mounting food shortages in many parts of the world, a rising demand for renewable raw materials for industry, and mobility. Against the backdrop of these and other mega-trends, he sees attractive development potential for Saltigo wherever innovative strength, know-how, flexibility and reliability are considered key customer expectations.
Core business: Custom Manufacturing
The custom synthesis of active ingredients and their precursors has been a core business for Saltigo ever since the company was first founded. It attributes its success to mature, efficient, environmentally sound and resource-conserving synthesis processes, and also to the high-quality substances it produces while ensuring maximum reliability. Whether a customer wants tiny quantities for laboratory trials or multi-ton batches for its commercial needs, Saltigo provides full support from start to finish. This continuity of the customer-supplier relationship is another of the company’s big plus points. In 2011, driven primarily by customer manufacturing, Saltigo was particularly successful on the agricultural products market, and the trend continued into Q1 of this year.
Research cooperation agreements with many notable academic institutions in Germany and abroad, extensive expertise in process development, and the piloting of new and further developed processes have all contributed to the acclaim Saltigo has won from its global partners in the agrochemical industry.
Growth market: Multi-customer products
Saltigo’s non-exclusively produced fine chemicals have very little in common with the classic catalogue commodities obtainable elsewhere on the chemicals market. They are raw materials and intermediates for polymer finishing, for aromas and flavorings, and for the electronics and cosmetics industries. "Here, too, quality and reliability are key," says Dirk Sandri, head of Marketing & Sales in the Agro & Fine Chemicals business line. “Product and process innovation plus extensive technical know-how are essential for meeting the customer’s requirements.”
Saltigo GmbH, headquartered in Langenfeld/Germany, is a leading supplier in the field of custom synthesis. The company of specialty chemicals group LANXESS belongs to the Advanced Intermediates segment, which achieved total sales in 2011 of EUR 1,545 million.
This news release may contain forward-looking statements based on current assumptions and forecasts made by LANXESS AG management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.